Oral domperidone has no additional effect on chronic functional constipation in children: A randomized clinical trial

Background Chronic constipation represents a common problem in children. The treatment of functional constipation is challenging. Some studies have investigated the effect of prokinetic agents as potential therapies for motility disorders of the lower gastrointestinal tract with paradoxical results....

Full description

Saved in:
Bibliographic Details
Published inIndian journal of gastroenterology Vol. 33; no. 2; pp. 125 - 130
Main Authors Dehghani, Seyed Mohsen, Askarian, Mehrdad, Kaffashan, Heidar Ali
Format Journal Article
LanguageEnglish
Published India Springer India 01.03.2014
Subjects
Online AccessGet full text
ISSN0254-8860
0975-0711
0975-0711
DOI10.1007/s12664-013-0375-5

Cover

Abstract Background Chronic constipation represents a common problem in children. The treatment of functional constipation is challenging. Some studies have investigated the effect of prokinetic agents as potential therapies for motility disorders of the lower gastrointestinal tract with paradoxical results. The present study aimed to investigate the effect of oral domperidone in the treatment of chronic functional constipation in children. Method A total of 105 children with chronic functional constipation (according to Rome III criteria) who were referred to the Pediatric Gastroenterology Clinic were recruited in this double-blind randomized clinical trial. The study subjects were randomly divided into two groups, the first of which received polyethylene glycol (PEG) solution 0.6 g/kg/day two times a day for 6 months and domperidone syrup 0.15 mL/kg three times a day for 3 months (case group) while the second one received PEG with the same dose for 6 months and placebo for 3 months with the same dose (control group). The two groups were compared regarding their symptoms and Rome III criteria through 1, 3, and 6 months following therapy. Primary outcome was response to treatment, and a response was defined as decrease in signs and symptoms that did not fulfill Rome III criteria. Secondary outcome measures were side effects during the course of treatment. Results A significant difference was observed both before and after PEG and domperidone treatment and before and after PEG and placebo treatment regarding Rome III criteria. There was no significant difference in response to treatment between the two study groups during 1 ( p  = 1), 3 ( p  = 0.799), and 6 ( p  = 0.403) month follow up periods. Also, the two groups were not significantly different regarding the Rome III criteria during the mentioned follow up periods. There were no side effects during the course of treatment. Conclusion There was no additional effect of domperidone as adjunct to PEG in the treatment of children with constipation.
AbstractList Chronic constipation represents a common problem in children. The treatment of functional constipation is challenging. Some studies have investigated the effect of prokinetic agents as potential therapies for motility disorders of the lower gastrointestinal tract with paradoxical results. The present study aimed to investigate the effect of oral domperidone in the treatment of chronic functional constipation in children.BACKGROUNDChronic constipation represents a common problem in children. The treatment of functional constipation is challenging. Some studies have investigated the effect of prokinetic agents as potential therapies for motility disorders of the lower gastrointestinal tract with paradoxical results. The present study aimed to investigate the effect of oral domperidone in the treatment of chronic functional constipation in children.A total of 105 children with chronic functional constipation (according to Rome III criteria) who were referred to the Pediatric Gastroenterology Clinic were recruited in this double-blind randomized clinical trial. The study subjects were randomly divided into two groups, the first of which received polyethylene glycol (PEG) solution 0.6 g/kg/day two times a day for 6 months and domperidone syrup 0.15 mL/kg three times a day for 3 months (case group) while the second one received PEG with the same dose for 6 months and placebo for 3 months with the same dose (control group). The two groups were compared regarding their symptoms and Rome III criteria through 1, 3, and 6 months following therapy. Primary outcome was response to treatment, and a response was defined as decrease in signs and symptoms that did not fulfill Rome III criteria. Secondary outcome measures were side effects during the course of treatment.METHODA total of 105 children with chronic functional constipation (according to Rome III criteria) who were referred to the Pediatric Gastroenterology Clinic were recruited in this double-blind randomized clinical trial. The study subjects were randomly divided into two groups, the first of which received polyethylene glycol (PEG) solution 0.6 g/kg/day two times a day for 6 months and domperidone syrup 0.15 mL/kg three times a day for 3 months (case group) while the second one received PEG with the same dose for 6 months and placebo for 3 months with the same dose (control group). The two groups were compared regarding their symptoms and Rome III criteria through 1, 3, and 6 months following therapy. Primary outcome was response to treatment, and a response was defined as decrease in signs and symptoms that did not fulfill Rome III criteria. Secondary outcome measures were side effects during the course of treatment.A significant difference was observed both before and after PEG and domperidone treatment and before and after PEG and placebo treatment regarding Rome III criteria. There was no significant difference in response to treatment between the two study groups during 1 (p = 1), 3 (p = 0.799), and 6 (p = 0.403) month follow up periods. Also, the two groups were not significantly different regarding the Rome III criteria during the mentioned follow up periods. There were no side effects during the course of treatment.RESULTSA significant difference was observed both before and after PEG and domperidone treatment and before and after PEG and placebo treatment regarding Rome III criteria. There was no significant difference in response to treatment between the two study groups during 1 (p = 1), 3 (p = 0.799), and 6 (p = 0.403) month follow up periods. Also, the two groups were not significantly different regarding the Rome III criteria during the mentioned follow up periods. There were no side effects during the course of treatment.There was no additional effect of domperidone as adjunct to PEG in the treatment of children with constipation.CONCLUSIONThere was no additional effect of domperidone as adjunct to PEG in the treatment of children with constipation.
Background Chronic constipation represents a common problem in children. The treatment of functional constipation is challenging. Some studies have investigated the effect of prokinetic agents as potential therapies for motility disorders of the lower gastrointestinal tract with paradoxical results. The present study aimed to investigate the effect of oral domperidone in the treatment of chronic functional constipation in children. Method A total of 105 children with chronic functional constipation (according to Rome III criteria) who were referred to the Pediatric Gastroenterology Clinic were recruited in this double-blind randomized clinical trial. The study subjects were randomly divided into two groups, the first of which received polyethylene glycol (PEG) solution 0.6 g/kg/day two times a day for 6 months and domperidone syrup 0.15 mL/kg three times a day for 3 months (case group) while the second one received PEG with the same dose for 6 months and placebo for 3 months with the same dose (control group). The two groups were compared regarding their symptoms and Rome III criteria through 1, 3, and 6 months following therapy. Primary outcome was response to treatment, and a response was defined as decrease in signs and symptoms that did not fulfill Rome III criteria. Secondary outcome measures were side effects during the course of treatment. Results A significant difference was observed both before and after PEG and domperidone treatment and before and after PEG and placebo treatment regarding Rome III criteria. There was no significant difference in response to treatment between the two study groups during 1 ( p  = 1), 3 ( p  = 0.799), and 6 ( p  = 0.403) month follow up periods. Also, the two groups were not significantly different regarding the Rome III criteria during the mentioned follow up periods. There were no side effects during the course of treatment. Conclusion There was no additional effect of domperidone as adjunct to PEG in the treatment of children with constipation.
Chronic constipation represents a common problem in children. The treatment of functional constipation is challenging. Some studies have investigated the effect of prokinetic agents as potential therapies for motility disorders of the lower gastrointestinal tract with paradoxical results. The present study aimed to investigate the effect of oral domperidone in the treatment of chronic functional constipation in children. A total of 105 children with chronic functional constipation (according to Rome III criteria) who were referred to the Pediatric Gastroenterology Clinic were recruited in this double-blind randomized clinical trial. The study subjects were randomly divided into two groups, the first of which received polyethylene glycol (PEG) solution 0.6 g/kg/day two times a day for 6 months and domperidone syrup 0.15 mL/kg three times a day for 3 months (case group) while the second one received PEG with the same dose for 6 months and placebo for 3 months with the same dose (control group). The two groups were compared regarding their symptoms and Rome III criteria through 1, 3, and 6 months following therapy. Primary outcome was response to treatment, and a response was defined as decrease in signs and symptoms that did not fulfill Rome III criteria. Secondary outcome measures were side effects during the course of treatment. A significant difference was observed both before and after PEG and domperidone treatment and before and after PEG and placebo treatment regarding Rome III criteria. There was no significant difference in response to treatment between the two study groups during 1 (p = 1), 3 (p = 0.799), and 6 (p = 0.403) month follow up periods. Also, the two groups were not significantly different regarding the Rome III criteria during the mentioned follow up periods. There were no side effects during the course of treatment. There was no additional effect of domperidone as adjunct to PEG in the treatment of children with constipation.
Author Askarian, Mehrdad
Dehghani, Seyed Mohsen
Kaffashan, Heidar Ali
Author_xml – sequence: 1
  givenname: Seyed Mohsen
  surname: Dehghani
  fullname: Dehghani, Seyed Mohsen
  email: dehghanism@sums.ac.ir
  organization: Gastroenterohepatology Research Center, Shiraz Transplant Research Center, Nemazee Teaching Hospital
– sequence: 2
  givenname: Mehrdad
  surname: Askarian
  fullname: Askarian, Mehrdad
  organization: Department of Community Medicine, School of Medicine, Shiraz University of Medical Sciences
– sequence: 3
  givenname: Heidar Ali
  surname: Kaffashan
  fullname: Kaffashan, Heidar Ali
  organization: Gastroenterohepatology Research Center, Shiraz Transplant Research Center, Nemazee Teaching Hospital
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23996739$$D View this record in MEDLINE/PubMed
BookMark eNp9kTtPwzAUhS1UREvhB7AgjywBO07shK2qeEmVusBsOX5QV6ld7GSAX49D2oWhk-_V_c6RfM4lmDjvNAA3GN1jhNhDxDmlRYYwyRBhZVaegRmq04AYxpM052WRVRVFU3AZ4xYNe00uwDQndU0ZqWegXwfRQuV3ex2sSvZwIyJ0HgqlbGe9S1dtjJYd9A7KTfDOSmh6Jw9H6V3s7F4MK7QDYlsVtHuECxiES872RysoW5uEie-CFe0VODeijfr68M7Bx_PT-_I1W61f3paLVSZJUXQZJlpSYggTpWkoxY2gxrBKNYzlxtSNNqKqpaIVxUrKglVIKiIRKhhpWC4aMgd3o-8--K9ex47vbJS6bYXTvo8clzhFVaAKJ_T2gPbNTiu-D3Ynwjc_RpUANgIy-BiDNlza7u_bXRC25RjxoRQ-lsJTKXwohZdJif8pj-anNPmoiYl1nzrwre9DCjyeEP0CvfWgZQ
CitedBy_id crossref_primary_10_1002_14651858_CD009118_pub3
crossref_primary_10_1097_MPG_0000000000003822
crossref_primary_10_5812_semj_68445
crossref_primary_10_1177_2333794X241274287
crossref_primary_10_3310_PLTR9622
Cites_doi 10.1097/00005176-199708000-00012
10.1097/00005176-199902000-00020
10.1136/adc.2007.128769
10.1136/gut.28.8.1033
10.1186/1471-230X-8-38
10.1590/S0100-879X2003001000016
10.1097/01.mpg.0000233159.97667.c3
10.1016/j.coph.2006.07.004
10.1111/j.1572-0241.2007.01255.x
10.1097/01.mpg.0000181188.01887.78
10.1111/j.1572-0241.2006.00771.x
10.1007/BF01311229
10.2165/00003495-199447010-00008
10.1016/S0022-3476(00)90046-5
10.1002/mds.870120618
10.1007/BF02063252
10.2165/00002018-199512060-00004
10.5056/jnm.2011.17.1.35
10.1053/j.gastro.2005.08.063
10.1097/01.mpg.0000232574.41149.0a
10.1097/00005176-200104001-00017
10.1016/j.jpeds.2008.01.039
10.1016/S0022-3476(00)90039-8
10.1002/14651858.CD007780.pub2
10.1007/BF02238599
ContentType Journal Article
Copyright Indian Society of Gastroenterology 2013
Copyright_xml – notice: Indian Society of Gastroenterology 2013
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1007/s12664-013-0375-5
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 0975-0711
EndPage 130
ExternalDocumentID 23996739
10_1007_s12664_013_0375_5
Genre Randomized Controlled Trial
Journal Article
GroupedDBID ---
-EM
06D
0R~
0VY
1N0
203
29I
29~
2CU
2KG
2VQ
2WC
30V
4.4
406
408
40D
53G
5GY
5VS
67Z
8TC
96X
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
AAZMS
ABAKF
ABDZT
ABECU
ABFTV
ABJNI
ABJOX
ABKCH
ABMQK
ABPLI
ABQBU
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABXPI
ACAOD
ACCUX
ACGFO
ACGFS
ACHSB
ACKNC
ACMDZ
ACMLO
ACOKC
ACPIV
ACREN
ACZOJ
ADBBV
ADHHG
ADINQ
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADYOE
ADZKW
AEBTG
AEFQL
AEGNC
AEGXH
AEJHL
AEJRE
AEMSY
AEOHA
AEPYU
AESKC
AETCA
AEVLU
AEXYK
AFBBN
AFLOW
AFQWF
AFWTZ
AFYQB
AFZKB
AGAYW
AGDGC
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHSBF
AIAGR
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALFXC
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AMXSW
AMYLF
AMYQR
ANMIH
AOCGG
AXYYD
BAWUL
BGNMA
C1A
CAG
COF
CSCUP
DDRTE
DIK
DNIVK
DPUIP
DU5
E3Z
EBLON
EBS
EIOEI
EJD
EN4
F5P
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FYJPI
GGCAI
GGRSB
GJIRD
GQ6
GQ7
GX1
H13
HF~
HG6
HMJXF
HRMNR
HZ~
I0C
IKXTQ
IWAJR
IXC
IXD
J-C
J0Z
JBSCW
JZLTJ
KOV
LLZTM
M4Y
MA-
NPVJJ
NQJWS
NU0
O9-
O93
O9I
O9J
OK1
P2P
P9S
PT4
R9I
RLLFE
ROL
RSV
S1Z
S27
S37
S3B
SDH
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SZ9
T13
TR2
TSG
U2A
U9L
UG4
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W2D
W48
WK8
XSB
Z45
Z7U
Z87
ZMTXR
ZOVNA
~A9
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ABRTQ
ACSTC
AEZWR
AFDZB
AFHIU
AFOHR
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
OVT
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c344t-13ec63f37a5fb661ba6ff78db772ff9befa89cd6861dcc4780cd3c00473b72ab3
IEDL.DBID AGYKE
ISSN 0254-8860
0975-0711
IngestDate Fri Sep 05 04:27:19 EDT 2025
Thu Apr 03 06:52:34 EDT 2025
Wed Oct 01 04:12:40 EDT 2025
Thu Apr 24 23:12:33 EDT 2025
Fri Feb 21 02:34:24 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Treatment
Children
Polyethylene glycol
Bowel disorder
Language English
License http://www.springer.com/tdm
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c344t-13ec63f37a5fb661ba6ff78db772ff9befa89cd6861dcc4780cd3c00473b72ab3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
PMID 23996739
PQID 1510714081
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_1510714081
pubmed_primary_23996739
crossref_citationtrail_10_1007_s12664_013_0375_5
crossref_primary_10_1007_s12664_013_0375_5
springer_journals_10_1007_s12664_013_0375_5
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20140300
2014-3-00
2014-Mar
20140301
PublicationDateYYYYMMDD 2014-03-01
PublicationDate_xml – month: 3
  year: 2014
  text: 20140300
PublicationDecade 2010
PublicationPlace India
PublicationPlace_xml – name: India
PublicationTitle Indian journal of gastroenterology
PublicationTitleAbbrev Indian J Gastroenterol
PublicationTitleAlternate Indian J Gastroenterol
PublicationYear 2014
Publisher Springer India
Publisher_xml – name: Springer India
References Soykan, Sarosiek, Shifflett, Wooten, McCallum (CR10) 1997; 12
Venkatasubramani, Rudolph, Sood (CR22) 2008; 8
Candy, Belsey (CR25) 2009; 94
Ahmad, Keith-Ferris, Gooden, Abell (CR24) 2006; 6
Loening-Baucke (CR6) 2001; 32
Nurko, Youssef, Sabri (CR27) 2008; 153
Baker, Liptak, Colletti (CR4) 2006; 43
Rasquin, Di Lorenzo, Forbes (CR9) 2006; 130
Sharma, Bhargava, Mathur (CR20) 1995; 40
Tack, Coremans, Janssens (CR12) 1995; 12
Longo, Vernava (CR8) 3rd; 36
Chung, Cheng, Goldman (CR5) 2009; 55
(CR18) 2006; 43
Wiseman, Cisapride (CR13) 1994; 47
Di Lorenzo (CR2) 2000; 136
van den Berg, Benninga, Di Lorenzo (CR1) 2006; 101
Shaman Rajindrajith, Devanarayana (CR3) 2011; 17
Halabi (CR15) 1999; 28
Bellomo-Brandao, Collares, da-Costa-Pinto (CR21) 2003; 36
Reddymasu, Soykan, McCallum (CR23) 2007; 102
CR7
Muller-Lissner (CR11) 1987; 28
Staiano, Cucchiara, Andreotti, Minella, Manzi (CR14) 1991; 36
Nurko, Garcia-Aranda, Worona, Zlochisty (CR17) 2000; 136
Odeka, Sagher, Miller, Doig (CR16) 1997; 24
Dupont, Leluyer, Maamri (CR26) 2005; 41
Dehghani, Imanieh, Erjaee, Moravej, Matin, Haghighat (CR19) 2012; 4
S Shaman Rajindrajith (375_CR3) 2011; 17
V Loening-Baucke (375_CR6) 2001; 32
C Dupont (375_CR26) 2005; 41
N Venkatasubramani (375_CR22) 2008; 8
A Rasquin (375_CR9) 2006; 130
MM Berg van den (375_CR1) 2006; 101
S Baker (375_CR4) 2006; 43
S Nurko (375_CR17) 2000; 136
SC Reddymasu (375_CR23) 2007; 102
LR Wiseman (375_CR13) 1994; 47
MA Bellomo-Brandao (375_CR21) 2003; 36
EB Odeka (375_CR16) 1997; 24
IM Halabi (375_CR15) 1999; 28
J Tack (375_CR12) 1995; 12
A Staiano (375_CR14) 1991; 36
North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (375_CR18) 2006; 43
N Ahmad (375_CR24) 2006; 6
D Candy (375_CR25) 2009; 94
375_CR8
375_CR7
SA Muller-Lissner (375_CR11) 1987; 28
375_CR5
SS Sharma (375_CR20) 1995; 40
375_CR2
I Soykan (375_CR10) 1997; 12
SM Dehghani (375_CR19) 2012; 4
S Nurko (375_CR27) 2008; 153
9399220 - Mov Disord. 1997 Nov;12(6):952-7
19019885 - Arch Dis Child. 2009 Feb;94(2):156-60
9252908 - J Pediatr Gastroenterol Nutr. 1997 Aug;25(2):199-203
10636964 - J Pediatr. 2000 Jan;136(1):4-7
11321420 - J Pediatr Gastroenterol Nutr. 2001;32 Suppl 1:S38-9
7587829 - Dig Dis Sci. 1995 Nov;40(11):2446-9
16954970 - J Pediatr Gastroenterol Nutr. 2006 Sep;43(3):405-7
19439699 - Can Fam Physician. 2009 May;55(5):481-2
8348856 - Dis Colon Rectum. 1993 Jul;36(7):696-708
3311905 - Gut. 1987 Aug;28(8):1033-8
18718006 - BMC Gastroenterol. 2008 Aug 21;8:38
16254521 - J Pediatr Gastroenterol Nutr. 2005 Nov;41(5):625-33
10636971 - J Pediatr. 2000 Jan;136(1):35-40
16678566 - Gastroenterology. 2006 Apr;130(5):1527-37
14502372 - Braz J Med Biol Res. 2003 Oct;36(10):1391-6
16997628 - Curr Opin Pharmacol. 2006 Dec;6(6):571-6
8527013 - Drug Saf. 1995 Jun;12(6):384-92
17032205 - Am J Gastroenterol. 2006 Oct;101(10):2401-9
9932855 - J Pediatr Gastroenterol Nutr. 1999 Feb;28(2):199-202
21369490 - J Neurogastroenterol Motil. 2011 Jan;17(1):35-47
7510617 - Drugs. 1994 Jan;47(1):116-52
21249695 - Cochrane Database Syst Rev. 2011 Jan 19;(1):CD007780
17488253 - Am J Gastroenterol. 2007 Sep;102(9):2036-45
2032513 - Dig Dis Sci. 1991 Jun;36(6):733-6
16954945 - J Pediatr Gastroenterol Nutr. 2006 Sep;43(3):e1-13
18534221 - J Pediatr. 2008 Aug;153(2):254-61, 261.e1
References_xml – volume: 24
  start-page: 199
  year: 1997
  end-page: 203
  ident: CR16
  article-title: Use of cisapride in treatment of constipation in children
  publication-title: J Pediatric Gastroenterol Nutr
  doi: 10.1097/00005176-199708000-00012
– volume: 28
  start-page: 199
  year: 1999
  end-page: 202
  ident: CR15
  article-title: Cisapride in management of chronic pediatric constipation
  publication-title: J Pediatr Gastroenterol Nutr
  doi: 10.1097/00005176-199902000-00020
– volume: 94
  start-page: 156
  year: 2009
  end-page: 160
  ident: CR25
  article-title: Macrogol (polyethylene glycol) laxatives in children with functional constipation and faecal impaction: a systematic review
  publication-title: Arch Dis Child
  doi: 10.1136/adc.2007.128769
– volume: 28
  start-page: 1033
  year: 1987
  end-page: 1038
  ident: CR11
  article-title: Bavarian Constipation Study Group. Treatment of chronic constipation with cisapride and placebo
  publication-title: Gut
  doi: 10.1136/gut.28.8.1033
– volume: 8
  start-page: 38
  year: 2008
  ident: CR22
  article-title: Erythromycin lacks colon prokinetic effect in children with functional gastrointestinal disorders: a retrospective study
  publication-title: BMC Gastroenterology
  doi: 10.1186/1471-230X-8-38
– volume: 55
  start-page: 481
  year: 2009
  end-page: 2
  ident: CR5
  article-title: Polyethylene glycol 3350 without electrolytes for treatment of childhood constipation
  publication-title: Can Fam Physician
– volume: 36
  start-page: 696
  year: 3rd
  end-page: 708
  ident: CR8
  article-title: Prokinetic agents for lower gastrointestinal motility disorders
  publication-title: Dis Colon Rectum
– volume: 36
  start-page: 1391
  year: 2003
  end-page: 1396
  ident: CR21
  article-title: Use of erythromycin for the treatment of severe chronic constipation in children
  publication-title: Braz J Med Biol Res
  doi: 10.1590/S0100-879X2003001000016
– volume: 43
  start-page: e1
  year: 2006
  end-page: 13
  ident: CR4
  article-title: Evaluation and treatment of constipation in infants and children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition
  publication-title: J Pediatr Gastroenterol Nutr
  doi: 10.1097/01.mpg.0000233159.97667.c3
– volume: 6
  start-page: 571
  year: 2006
  end-page: 576
  ident: CR24
  article-title: Making a case for domperidone in the treatment of gastrointestinal motility disorders
  publication-title: Curr Opin Pharmacol
  doi: 10.1016/j.coph.2006.07.004
– volume: 102
  start-page: 2036
  year: 2007
  end-page: 2045
  ident: CR23
  article-title: Domperidone: review of pharmacology and clinical applications in gastroenterology
  publication-title: Am J Gastroenterol
  doi: 10.1111/j.1572-0241.2007.01255.x
– volume: 41
  start-page: 625
  year: 2005
  end-page: 633
  ident: CR26
  article-title: Double-blind randomized evaluation of clinical and biological tolerance of polyethylene glycol 4000 versus lactulose in constipated children
  publication-title: J Pediatr Gastroenterol Nutr
  doi: 10.1097/01.mpg.0000181188.01887.78
– volume: 101
  start-page: 2401
  year: 2006
  end-page: 2409
  ident: CR1
  article-title: Epidemiology of childhood constipation: a systematic review
  publication-title: Am J Gastroenterol
  doi: 10.1111/j.1572-0241.2006.00771.x
– volume: 36
  start-page: 733
  year: 1991
  end-page: 736
  ident: CR14
  article-title: Effect of cisapride on chronic idiopathic constipation in children
  publication-title: Dig Dis Sci
  doi: 10.1007/BF01311229
– volume: 47
  start-page: 116
  year: 1994
  end-page: 152
  ident: CR13
  article-title: An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders
  publication-title: Drugs
  doi: 10.2165/00003495-199447010-00008
– volume: 136
  start-page: 35
  year: 2000
  end-page: 40
  ident: CR17
  article-title: Cisapride for the treatment of constipation in children : a double-blind study
  publication-title: J Pediatr
  doi: 10.1016/S0022-3476(00)90046-5
– volume: 4
  start-page: e 144
  year: 2012
  ident: CR19
  article-title: The role of metoclopramide for treatment of functional constipation in children: a double blind study
  publication-title: J Ped Sci
– volume: 12
  start-page: 952
  year: 1997
  end-page: 957
  ident: CR10
  article-title: Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease
  publication-title: Mov Disord
  doi: 10.1002/mds.870120618
– ident: CR7
– volume: 40
  start-page: 2446
  year: 1995
  end-page: 2449
  ident: CR20
  article-title: Effect of oral erythromycin on colonic transit in patients with idiopathic constipation. A pilot study
  publication-title: Dig Dis Sci
  doi: 10.1007/BF02063252
– volume: 12
  start-page: 384
  year: 1995
  end-page: 392
  ident: CR12
  article-title: A risk-benefit assessment of cisapride in the treatment of gastrointestinal disorders
  publication-title: Drug Saf
  doi: 10.2165/00002018-199512060-00004
– volume: 17
  start-page: 35
  year: 2011
  end-page: 47
  ident: CR3
  article-title: Constipation in children: novel insight into epidemiology, pathophysiology and management
  publication-title: J Neurogastroenterol Motil
  doi: 10.5056/jnm.2011.17.1.35
– volume: 130
  start-page: 1527
  year: 2006
  end-page: 1537
  ident: CR9
  article-title: Childhood functional gastrointestinal disorders: child/adolescent
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2005.08.063
– volume: 43
  start-page: 405
  year: 2006
  end-page: 407
  ident: CR18
  article-title: Evaluation and treatment of constipation in children: summary of updated recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition
  publication-title: J Pediatr Gastroenterol Nutr
  doi: 10.1097/01.mpg.0000232574.41149.0a
– volume: 32
  start-page: S38
  year: 2001
  end-page: S39
  ident: CR6
  article-title: Controversies in the management of chronic constipation
  publication-title: J Pediatr Gastroenterol Nutr
  doi: 10.1097/00005176-200104001-00017
– volume: 153
  start-page: 254
  year: 2008
  end-page: 261
  ident: CR27
  article-title: PEG3350 in the treatment of childhood constipation: a multicenter, double-blinded, placebo-controlled trial
  publication-title: J Pediatr
  doi: 10.1016/j.jpeds.2008.01.039
– volume: 136
  start-page: 4
  year: 2000
  ident: CR2
  article-title: Childhood constipation: finally some hard data about hard stools!
  publication-title: J Pediatr
– ident: 375_CR2
  doi: 10.1016/S0022-3476(00)90039-8
– volume: 47
  start-page: 116
  year: 1994
  ident: 375_CR13
  publication-title: Drugs
  doi: 10.2165/00003495-199447010-00008
– ident: 375_CR5
– volume: 24
  start-page: 199
  year: 1997
  ident: 375_CR16
  publication-title: J Pediatric Gastroenterol Nutr
  doi: 10.1097/00005176-199708000-00012
– volume: 94
  start-page: 156
  year: 2009
  ident: 375_CR25
  publication-title: Arch Dis Child
  doi: 10.1136/adc.2007.128769
– volume: 28
  start-page: 1033
  year: 1987
  ident: 375_CR11
  publication-title: Gut
  doi: 10.1136/gut.28.8.1033
– volume: 6
  start-page: 571
  year: 2006
  ident: 375_CR24
  publication-title: Curr Opin Pharmacol
  doi: 10.1016/j.coph.2006.07.004
– volume: 12
  start-page: 384
  year: 1995
  ident: 375_CR12
  publication-title: Drug Saf
  doi: 10.2165/00002018-199512060-00004
– volume: 130
  start-page: 1527
  year: 2006
  ident: 375_CR9
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2005.08.063
– volume: 28
  start-page: 199
  year: 1999
  ident: 375_CR15
  publication-title: J Pediatr Gastroenterol Nutr
  doi: 10.1097/00005176-199902000-00020
– volume: 8
  start-page: 38
  year: 2008
  ident: 375_CR22
  publication-title: BMC Gastroenterology
  doi: 10.1186/1471-230X-8-38
– volume: 4
  start-page: e 144
  year: 2012
  ident: 375_CR19
  publication-title: J Ped Sci
– volume: 36
  start-page: 733
  year: 1991
  ident: 375_CR14
  publication-title: Dig Dis Sci
  doi: 10.1007/BF01311229
– ident: 375_CR7
  doi: 10.1002/14651858.CD007780.pub2
– volume: 102
  start-page: 2036
  year: 2007
  ident: 375_CR23
  publication-title: Am J Gastroenterol
  doi: 10.1111/j.1572-0241.2007.01255.x
– volume: 101
  start-page: 2401
  year: 2006
  ident: 375_CR1
  publication-title: Am J Gastroenterol
  doi: 10.1111/j.1572-0241.2006.00771.x
– volume: 36
  start-page: 1391
  year: 2003
  ident: 375_CR21
  publication-title: Braz J Med Biol Res
  doi: 10.1590/S0100-879X2003001000016
– volume: 43
  start-page: e1
  year: 2006
  ident: 375_CR4
  publication-title: J Pediatr Gastroenterol Nutr
  doi: 10.1097/01.mpg.0000233159.97667.c3
– volume: 41
  start-page: 625
  year: 2005
  ident: 375_CR26
  publication-title: J Pediatr Gastroenterol Nutr
  doi: 10.1097/01.mpg.0000181188.01887.78
– volume: 136
  start-page: 35
  year: 2000
  ident: 375_CR17
  publication-title: J Pediatr
  doi: 10.1016/S0022-3476(00)90046-5
– volume: 153
  start-page: 254
  year: 2008
  ident: 375_CR27
  publication-title: J Pediatr
  doi: 10.1016/j.jpeds.2008.01.039
– volume: 40
  start-page: 2446
  year: 1995
  ident: 375_CR20
  publication-title: Dig Dis Sci
  doi: 10.1007/BF02063252
– volume: 12
  start-page: 952
  year: 1997
  ident: 375_CR10
  publication-title: Mov Disord
  doi: 10.1002/mds.870120618
– ident: 375_CR8
  doi: 10.1007/BF02238599
– volume: 43
  start-page: 405
  year: 2006
  ident: 375_CR18
  publication-title: J Pediatr Gastroenterol Nutr
  doi: 10.1097/01.mpg.0000232574.41149.0a
– volume: 17
  start-page: 35
  year: 2011
  ident: 375_CR3
  publication-title: J Neurogastroenterol Motil
  doi: 10.5056/jnm.2011.17.1.35
– volume: 32
  start-page: S38
  year: 2001
  ident: 375_CR6
  publication-title: J Pediatr Gastroenterol Nutr
  doi: 10.1097/00005176-200104001-00017
– reference: 14502372 - Braz J Med Biol Res. 2003 Oct;36(10):1391-6
– reference: 9399220 - Mov Disord. 1997 Nov;12(6):952-7
– reference: 7587829 - Dig Dis Sci. 1995 Nov;40(11):2446-9
– reference: 21249695 - Cochrane Database Syst Rev. 2011 Jan 19;(1):CD007780
– reference: 18718006 - BMC Gastroenterol. 2008 Aug 21;8:38
– reference: 8348856 - Dis Colon Rectum. 1993 Jul;36(7):696-708
– reference: 18534221 - J Pediatr. 2008 Aug;153(2):254-61, 261.e1
– reference: 16997628 - Curr Opin Pharmacol. 2006 Dec;6(6):571-6
– reference: 2032513 - Dig Dis Sci. 1991 Jun;36(6):733-6
– reference: 19019885 - Arch Dis Child. 2009 Feb;94(2):156-60
– reference: 16954945 - J Pediatr Gastroenterol Nutr. 2006 Sep;43(3):e1-13
– reference: 10636964 - J Pediatr. 2000 Jan;136(1):4-7
– reference: 9932855 - J Pediatr Gastroenterol Nutr. 1999 Feb;28(2):199-202
– reference: 21369490 - J Neurogastroenterol Motil. 2011 Jan;17(1):35-47
– reference: 16954970 - J Pediatr Gastroenterol Nutr. 2006 Sep;43(3):405-7
– reference: 16254521 - J Pediatr Gastroenterol Nutr. 2005 Nov;41(5):625-33
– reference: 16678566 - Gastroenterology. 2006 Apr;130(5):1527-37
– reference: 11321420 - J Pediatr Gastroenterol Nutr. 2001;32 Suppl 1:S38-9
– reference: 17032205 - Am J Gastroenterol. 2006 Oct;101(10):2401-9
– reference: 17488253 - Am J Gastroenterol. 2007 Sep;102(9):2036-45
– reference: 7510617 - Drugs. 1994 Jan;47(1):116-52
– reference: 3311905 - Gut. 1987 Aug;28(8):1033-8
– reference: 10636971 - J Pediatr. 2000 Jan;136(1):35-40
– reference: 19439699 - Can Fam Physician. 2009 May;55(5):481-2
– reference: 8527013 - Drug Saf. 1995 Jun;12(6):384-92
– reference: 9252908 - J Pediatr Gastroenterol Nutr. 1997 Aug;25(2):199-203
SSID ssj0025493
Score 1.9890338
Snippet Background Chronic constipation represents a common problem in children. The treatment of functional constipation is challenging. Some studies have...
Chronic constipation represents a common problem in children. The treatment of functional constipation is challenging. Some studies have investigated the...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 125
SubjectTerms Administration, Oral
Child
Child, Preschool
Chronic Disease
Constipation - drug therapy
Domperidone - administration & dosage
Dopamine Antagonists - administration & dosage
Female
Gastroenterology
Hepatology
Humans
Laxatives - administration & dosage
Male
Medicine
Medicine & Public Health
Original Article
Polyethylene Glycols - administration & dosage
Treatment Outcome
Title Oral domperidone has no additional effect on chronic functional constipation in children: A randomized clinical trial
URI https://link.springer.com/article/10.1007/s12664-013-0375-5
https://www.ncbi.nlm.nih.gov/pubmed/23996739
https://www.proquest.com/docview/1510714081
Volume 33
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 0975-0711
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0025493
  issn: 0254-8860
  databaseCode: DIK
  dateStart: 19820101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 0975-0711
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0025493
  issn: 0254-8860
  databaseCode: GX1
  dateStart: 19820101
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVLSH
  databaseName: SpringerLink Journals
  customDbUrl:
  mediaType: online
  eissn: 0975-0711
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0025493
  issn: 0254-8860
  databaseCode: AFBBN
  dateStart: 20090101
  isFulltext: true
  providerName: Library Specific Holdings
– providerCode: PRVAVX
  databaseName: SpringerLINK - Czech Republic Consortium
  customDbUrl:
  eissn: 0975-0711
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0025493
  issn: 0254-8860
  databaseCode: AGYKE
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: http://link.springer.com
  providerName: Springer Nature
– providerCode: PRVAVX
  databaseName: SpringerLink Journals (ICM)
  customDbUrl:
  eissn: 0975-0711
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0025493
  issn: 0254-8860
  databaseCode: U2A
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: http://www.springerlink.com/journals/
  providerName: Springer Nature
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ZS8NAEB60BfHF-6hHWcEnZSXt5qpvRdRqUV9a0KewJxYllR4v_npns5uKVgVfQsJuJtkjO99mvpkBOGYKtTAPEioiwWnIDadCs4jaaHNGpto0i6wld_dxpx_ePkaP3o97XLLdS5NksVJ_OruhLrGMCUZt3lYaLUI1QnQcVaDavn7qXs72WbjlKQzLeELTNJ4ZM38S8lUdzWHMOftooXauVqFXvrBjm7ycTSfiTL5_i-X4zxatwYqHoaTt5s06LOh8A5buvKF9E6YPIyxWFlSPBmqYa_LMxyQfEss_cr8PiaOCkGFOpIuwS6yS9IXS4k5P1yYDW8U5jZ-TNkH1iJIH71qR0jGTFNlDtqB_ddm76FCfoYFKFoY2j72WMTMs4ZERqOkFj41JUiUQsxvTEtrwtCVVnMYNJWWYpIFUTNoIlUwkTS7YNlRybMMuEBZwyQyiKaNUaBLGG1LgdcxbgUDZjRoE5UBl0ocvt1k0XrPPwMu2OzPszsx2ZxbV4GR2y5uL3fFX5aNy9DP8wqzZhOd6OB1niImslxdipxrsuGkxE2c9g-OEtWpwWg5x5heB8e_P2vtX7X1YRpQWOuLbAVQmo6k-RCQ0EXU_8-u4F7jp4rHfbH8AFiEB2A
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1JS8NAFH5oBfUi7tZ1BE_KQNrJ6q2IpWpbLy30NsyKBUmlaS_-et9kaZGq4C0hkxeSL5Pvm7wN4IZpZGHhRVQGUlBfWEGlYQF11easio1t5l1Lev2wM_SfR8GozOPOqmj3yiWZf6mXyW7IJS5iglHXt5UG67CBWiCfjcNma7HKwgVP7lbGDRrH4cKV-ZOJ72S0ojBXvKM56bR3YadUi6RVwLsHaybdh81e6Q8_gPnrFA9rp32nYz1JDXkTGUknxIUJFX_5SBGxQSYpUUUhXOK4rDyonDwso6rJ2A0pcrvvSYsgi6Hl8afRpMqfJHmTj0MYth8HDx1aNlKgivm-azdvVMgsi0RgJRKyFKG1UawlSmtrE2msiBOlwzhsaKX8KPaUZsoVkmQyagrJjqCW4j2cAGGeUMyi6LFa-zZioqEk7oci8STabtTBq54oV2WVcdfs4p0v6yM7EDiCwB0IPKjD7eKUj6LExl-DryuYOE4E590QqZnMM47SxSVjocSpw3GB38KcS-ANI5bU4a4ClJdzNfv9Wqf_Gn0FW51Br8u7T_2XM9hGYeUXsWrnUJtN5-YCxctMXuYv6xeWluYE
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Ja9tAFH5kAZNLaLM6bZoJ9NQwRPZoc28mrXEWpz3E4NswKzEE2Xi55NfnPY3kELJAbhIzekL6NLxv9JYP4Kew6IVVlHGdaMVj5RXXTiScus15kzvfLlVLBrdpfxhfjZJRpXM6r7Pd65BkqGmgLk3F4nxq_flz4Rv6FcqeEJw0XHmyDpsko0wSBsN2d7Xjws1PGWLGA57n6Sqs-ZaJl47pFdt8FSktHVDvC2xXzJF1A9RfYc0VO9AYVLHxXVj-m-GwJR48G9tJ4di9mrNiwihlKPzxYyF7g00KZkJTXEZ-rRo0RBWrDGs2pimhzvs36zL0aGh5_Ogsq2spWSn4sQfD3t-7iz6vRBW4EXFM0vPOpMKLTCVeo3PWKvU-y61Gmu19Rzuv8o6xaZ62rDFxlkfGCkNNJYXO2kqLfdgo8BkOgYlIGeGRAHlrY58J1TIaz1PViTTabjUhqt-oNFXHcRK-eJDPvZIJBIkgSAJBJk34tbpkGtptfDT5tIZJ4qKgSIcq3GQ5l0hjqDAL6U4TDgJ-K3NUzJtmotOEsxpQWa3b-fv3OvrU7BNo_P_TkzeXt9ffYAs5VhzS1r7DxmK2dMfIYxb6R_mtPgHvM-pJ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Oral+domperidone+has+no+additional+effect+on+chronic+functional+constipation+in+children%3A+A+randomized+clinical+trial&rft.jtitle=Indian+journal+of+gastroenterology&rft.au=Dehghani%2C+Seyed+Mohsen&rft.au=Askarian%2C+Mehrdad&rft.au=Kaffashan%2C+Heidar+Ali&rft.date=2014-03-01&rft.pub=Springer+India&rft.issn=0254-8860&rft.eissn=0975-0711&rft.volume=33&rft.issue=2&rft.spage=125&rft.epage=130&rft_id=info:doi/10.1007%2Fs12664-013-0375-5&rft.externalDocID=10_1007_s12664_013_0375_5
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0254-8860&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0254-8860&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0254-8860&client=summon